Cargando…

Identification of Mutation Landscape and Immune Cell Component for Liver Hepatocellular Carcinoma Highlights Potential Therapeutic Targets and Prognostic Markers

Liver hepatocellular carcinoma (LIHC) is a primary malignancy, and there is a lack of effective treatment for advanced patients. Although numerous studies exist to reveal the carcinogenic mechanism of LIHC, few studies have integrated multi-omics data to systematically analyze pathogenesis and revea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hengzhen, Jiang, Wenjing, Wang, Haijun, Wei, Zheng, Li, Hali, Yan, Haichao, Han, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481807/ https://www.ncbi.nlm.nih.gov/pubmed/34603396 http://dx.doi.org/10.3389/fgene.2021.737965

Ejemplares similares

Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma
por: Zhao, Yidi, et al.
Publicado: (2022)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer
por: Cheng, Tianyi, et al.
Publicado: (2022)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma
por: Zhang, Xiuzhi, et al.
Publicado: (2020)

Analysis of Variance Components for Genetic Markers with Unphased Genotypes
por: Wang, Tao
Publicado: (2016)

N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022)

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms
por: Liu, Man, et al.
Publicado: (2023)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Overexpression of TCERG1 as a prognostic marker in hepatocellular carcinoma: A TCGA data-based analysis
por: Yang, Pan, et al.
Publicado: (2022)

Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC
por: Ning, Jinfeng, et al.
Publicado: (2021)

A necroptosis-related prognostic model for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma based on single-cell sequencing analysis and weighted co-expression network
por: Li, Jingjing, et al.
Publicado: (2022)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
por: Bolli, Niccolo, et al.
Publicado: (2018)

Multiomics Analysis Reveals the Prognostic Non-tumor Cell Landscape in Glioblastoma Niches
por: Xiao, Zixuan, et al.
Publicado: (2021)

Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma
por: Fan, Xiaoyan, et al.
Publicado: (2022)

Advances in single-cell sequencing technology in the field of hepatocellular carcinoma
por: Qin, Rongyi, et al.
Publicado: (2022)

Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma
por: Sang, Xiaopu, et al.
Publicado: (2020)

Identification of subtypes of hepatocellular carcinoma and screening of prognostic molecular diagnostic markers based on cell adhesion molecule related genes
por: Sun, Ruge, et al.
Publicado: (2022)

Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma
por: Wu, Qiong, et al.
Publicado: (2022)

Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma
por: Lu, Qian, et al.
Publicado: (2022)

Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma
por: Wang, Xin, et al.
Publicado: (2022)

Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma
por: Wang, Liangliang, et al.
Publicado: (2022)

Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence
por: Fu, Min, et al.
Publicado: (2021)

Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma
por: Pan, Chenxi, et al.
Publicado: (2022)

CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
por: Meng, Ming, et al.
Publicado: (2022)

The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study
por: Neri, Marcella, et al.
Publicado: (2020)

The Landscape of the Tumor-Infiltrating Immune Cell and Prognostic Nomogram in Colorectal Cancer
por: Zhong, Jiateng, et al.
Publicado: (2022)

Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma
por: Wang, Pei, et al.
Publicado: (2020)

PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2022)

Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma
por: Li, Huawei, et al.
Publicado: (2021)

Prognostic value of LECT2 and relevance to immune infiltration in hepatocellular carcinoma
por: Qin, Jiangfeng, et al.
Publicado: (2022)

Construction of a prognostic model based on eight ubiquitination-related genes via machine learning and potential therapeutics analysis for cervical cancer
por: Hao, Yiping, et al.
Publicado: (2023)

Integrative pan-cancer landscape of MMS22L and its potential role in hepatocellular carcinoma
por: Guo, Zhiting, et al.
Publicado: (2022)

Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma
por: Wang, Wen-Jie, et al.
Publicado: (2020)

Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma
por: Liang, Tao-tao, et al.
Publicado: (2020)

Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer
por: Yang, Linqi, et al.
Publicado: (2022)

Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma
por: Chen, Xingte, et al.
Publicado: (2021)

Bioinformatics Analysis of Differentially Expressed Rhythm Genes in Liver Hepatocellular Carcinoma
por: Liu, Huaifeng, et al.
Publicado: (2021)

The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma
por: Zhang, Xiulei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3u4liooeq9fduda21jglqmrljo